623 related articles for article (PubMed ID: 21211868)
1. [Neuroimaging in brain tumors].
Arbizu J; Domínguez PD; Diez-Valle R; Vigil C; García-Eulate R; Zubieta JL; Richter JA
Rev Esp Med Nucl; 2011; 30(1):47-65. PubMed ID: 21211868
[TBL] [Abstract][Full Text] [Related]
2. [Use of the functional imaging modalities in radiation therapy treatment planning in patients with glioblastoma].
Dhermain F; Ducreux D; Bidault F; Bruna A; Parker F; Roujeau T; Beaudre A; Armand JP; Haie-Meder C
Bull Cancer; 2005 Apr; 92(4):333-42. PubMed ID: 15888390
[TBL] [Abstract][Full Text] [Related]
3. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
[TBL] [Abstract][Full Text] [Related]
4. [Use of amino acid PET in the Diagnostic and Treatment Management of cerebral gliomas].
Galldiks N; Langen KJ
Fortschr Neurol Psychiatr; 2012 Jan; 80(1):17-23. PubMed ID: 22161228
[TBL] [Abstract][Full Text] [Related]
5. Multimodality assessment of brain tumors and tumor recurrence.
Heiss WD; Raab P; Lanfermann H
J Nucl Med; 2011 Oct; 52(10):1585-600. PubMed ID: 21840931
[TBL] [Abstract][Full Text] [Related]
6. Comparison of diffusion tensor, dynamic susceptibility contrast MRI and (99m)Tc-Tetrofosmin brain SPECT for the detection of recurrent high-grade glioma.
Alexiou GA; Zikou A; Tsiouris S; Goussia A; Kosta P; Papadopoulos A; Voulgaris S; Tsekeris P; Kyritsis AP; Fotopoulos AD; Argyropoulou MI
Magn Reson Imaging; 2014 Sep; 32(7):854-9. PubMed ID: 24848292
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 18F-FET PET and perfusion-weighted MR imaging: a PET/MR imaging hybrid study in patients with brain tumors.
Filss CP; Galldiks N; Stoffels G; Sabel M; Wittsack HJ; Turowski B; Antoch G; Zhang K; Fink GR; Coenen HH; Shah NJ; Herzog H; Langen KJ
J Nucl Med; 2014 Apr; 55(4):540-5. PubMed ID: 24578243
[TBL] [Abstract][Full Text] [Related]
8. 11C-CHO PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas.
Li FM; Nie Q; Wang RM; Chang SM; Zhao WR; Zhu Q; Liang YK; Yang P; Zhang J; Jia HW; Fang HH
Nucl Med Biol; 2012 Apr; 39(3):437-42. PubMed ID: 22172386
[TBL] [Abstract][Full Text] [Related]
9. Cerebral tumors: specific features in children.
Koob M; Girard N
Diagn Interv Imaging; 2014 Oct; 95(10):965-83. PubMed ID: 25150727
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of brain tumor recurrence by (99m)Tc-tetrofosmin SPECT: a prospective pilot study.
Alexiou GA; Fotopoulos AD; Papadopoulos A; Kyritsis AP; Polyzoidis KS; Tsiouris S
Ann Nucl Med; 2007 Jul; 21(5):293-8. PubMed ID: 17634847
[TBL] [Abstract][Full Text] [Related]
11. The demonstration of extension of high-grade glioma beyond magnetic resonance imaging defined edema by the use of (11) C-methionine positron emission tomography.
Susheela SP; Revannasiddaiah S; Madhusudhan N; Bijjawara M
J Cancer Res Ther; 2013; 9(4):715-7. PubMed ID: 24518724
[TBL] [Abstract][Full Text] [Related]
12. Single-photon emission computed tomography/computed tomography in brain tumors.
Schillaci O; Filippi L; Manni C; Santoni R
Semin Nucl Med; 2007 Jan; 37(1):34-47. PubMed ID: 17161038
[TBL] [Abstract][Full Text] [Related]
13. [Multimodal magnetic resonance imaging of brain tumors].
Guillevin R; Menuel C; Vallée JN
Rev Neurol (Paris); 2011 Oct; 167(10):704-14. PubMed ID: 21903235
[TBL] [Abstract][Full Text] [Related]
14. Advances in Magnetic Resonance Imaging and Positron Emission Tomography Imaging for Grading and Molecular Characterization of Glioma.
Chung C; Metser U; Ménard C
Semin Radiat Oncol; 2015 Jul; 25(3):164-71. PubMed ID: 26050586
[TBL] [Abstract][Full Text] [Related]
15. Focal changes in diffusivity on apparent diffusion coefficient MR imaging and amino acid uptake on PET do not colocalize in nonenhancing low-grade gliomas.
Rahm V; Boxheimer L; Bruehlmeier M; Berberat J; Nitzsche EU; Remonda L; Roelcke U
J Nucl Med; 2014 Apr; 55(4):546-50. PubMed ID: 24566001
[TBL] [Abstract][Full Text] [Related]
16. Clinical applications of imaging biomarkers. Part 2. The neurosurgeon's perspective.
Brodbelt A
Br J Radiol; 2011 Dec; 84 Spec No 2(Spec Iss 2):S205-8. PubMed ID: 22433829
[TBL] [Abstract][Full Text] [Related]
17. Imaging gliomas with positron emission tomography and single-photon emission computed tomography.
Bénard F; Romsa J; Hustinx R
Semin Nucl Med; 2003 Apr; 33(2):148-62. PubMed ID: 12756647
[TBL] [Abstract][Full Text] [Related]
18. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography imaging in gliomas: applications in clinical diagnosis, for assessment of prognosis and of treatment effects, and for detection of recurrences.
Heiss WD
Eur J Neurol; 2017 Oct; 24(10):1255-e70. PubMed ID: 28799683
[TBL] [Abstract][Full Text] [Related]
20. Accurate Delineation of Glioma Infiltration by Advanced PET/MR Neuro-Imaging (FRONTIER Study): A Diagnostic Study Protocol.
Verburg N; Pouwels PJ; Boellaard R; Barkhof F; Hoekstra OS; Reijneveld JC; Vandertop WP; Wesseling P; de Witt Hamer PC
Neurosurgery; 2016 Oct; 79(4):535-40. PubMed ID: 27479710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
